Combination Chemotherapy in Advanced Adrenocortical CarcinomaMartin Faßnacht, Britt Skogseid, Anders Sundin et al.|New England Journal of Medicine|2012Cited by 863
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid CancersLori J. Wirth, Maria E. Cabanillas, Eric J. Sherman et al.|New England Journal of Medicine|2020Cited by 766
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersPeter Horak, Klaus Schulze‐Osthoff, Christoph Heining et al.|Cancer Discovery|2021Cited by 282
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort studyTimo Deutschbein, Marco Boscaro, Giuseppe Reimondo et al.|The Lancet Diabetes & Endocrinology|2022Cited by 180
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinomaKatia Mariniello, Leonardo Guasti, James Pittaway et al.|Cancer Communications|2025Cited by 6